Investment Q&A

Q: HI 5i staff. Can I have your take on HAI's recently published financial results. Do you think the worse is over for this company and continue to hold it as a long term hold or should I purchase something else with better growth potential?
Thank you

Q: Butterfly Network (NYSE:BFLY) Cathy Wood bought it. Would you?

What is it's potential?

Can you explain in layman's terms what it does & who buys this stuff?

Thank you.

Q: Good evening
BCE, according to a financial analyst, paid 114% of profit in the past year as dividends. As well , BCE paid 351% of their free cash flow in dividends during the last year.
The analyst further concludes that this is unsustainable and that BCE dividend could be cut.
Can you please provide us with your opinion regarding the sustainability of the BCE dividend?
Thank you

Q: I have a loss in VEEV of 30%. Was thinking of ROKU as a buy. I am equal weight between Consumer discretionary and healthcare with better diversification in HC.
Which as better growth ahead? Which do you prefer?

Q: Your thoughts on this stock and hold /buy attractiveness?

Q: First thanks for the swift turnaround response for ADBE, yesterday. 
Now my focus is on Consumer Discretionary stock positions. I hold Canadian positions in ATD, BYD, DOL and PLC and then for the US, AMZN and HD. 
For the Cdn positions, all exceed the target weightings. But for AMZN, which I recently added to, the portfolio for this stock is underweight by 1.2% and for HD, underweight by 1.3%.
At this time, the total CD sector portfolio weighting is  13.5% compared to a target of 10% but me, comfortable going overweight this sector as I shy away from energy and materials.
I'm inclined to add to Home Depot next. What are your thoughts about adding to HD, especially looking forward to a brighter horizon?
Another one is ATZ which I have held in the past. Wondering about buying ATZ in the near term or wait awhile???
If there are other companies in the CD or Cyclic sector that you think I should consider for the brighter future, I'd be pleased to know about them.........Much thanks..............Tom

Q: Hello Peter,
Given your response to Topicus, is the company following the same strategy as it did for CSU? If so, given that its presence in Europe and that it trades on Venture exchange with little coverage, can you see this stock doing well in the longer term? Also, why would CSU not focus on getting the company to trade on Toronto Exchange? Lastly , Tecsys has been on the decline.. Any major reason as i thought this would be a good long term hold? Thanks

Q: Please educate me on the lack of insider activity on this one. The news sounds very positive yet no insiders seem to be buying in the public markets or otherwise adding to their positions, that I can see anyway? I realize that the insiders have options so can you tell me who holds these options and what the terms are?

Q: Your comments please on the FDA clearance. Any idea what the size of the market is for their product? What is their cash situation like... does it seem likely that they may need a financing round in the short term? Thanks.

Q: Your opinion on HISA, please... The ETF sponsored by Evolve Funds. Also The HISA in US funds for short term holdings. Thanks

Q: Hi there, I'm building a portfolio based on the 4% withdrawal rule. I read a study where based on country specific stock market data, the 4% withdrawal rule only worked in Canada, US and maybe 3 other countries. Based on this study and using history as a guide - if one were to build a portfolio with 50/50 Canada and US exposure, would it be best to use VCE and VFV or VCE and XSP? Also, if VCE is not the most appropriate Canadian ETF, what would be the most suitable? I've seen XIU, XIC and VCN often mentioned, but it appears like VCE has a slight outperformance?

Thanks!

Q: Hello Peter,
Thanks for your explanation to a question asked earlier on BAM; sorry, are you able to expand a bit. If one owned 100 shares of BAM, what would happen as you mentioned 1 for 4 basis. Does this mean BAM will still trade as BAM, and another company will trade as XXX, but as a shareholder 400 shares would be in the account or 25 shares? Also, what would happen to BIP, and BEP as there seems to be an overlap.. Much appreciated. Finally, if one owns BAM today, should one just stay put and hold the shares... thanks very much

Q: Hello 5i,
In the September market and report updates there is no mention of information regarding additions or removal of holdings in any of the portfolios. Have I missed something? Usually there s a mention of no movement to a given portfolio.
Thank you
Stanley

Q: Is Adobe a screaming buy today, Thursday, as it is now down 12.7% today as I keyboard this email to you???.......or wait until it settles down???.....Tom

Q: What is your point on view on DLR and on Data centers ,would you sell ,keep,or switch DLR now (at lowest in 52 weeks) for another REIT or a data center ETF ? thanks

Q: My question is on BOARDWALKTECH SOFTWARE. I've read your last comments but I’m just trying to understand what industry this company caters to. Where do they derive their revenues from and is the CAGR (Compounded Annual Growth Rate) for this particular industry good looking forward? If you were going to add this to a microcap portfolio would you do it here as it is getting close to 52 week highs or wait for a pull back, or just stay away from it period and sell, sell, sell if you already have a position?

Q: good morning,
Sold this one for a tax loss about 35 days ago. What do you think about recent earnings and forecast?
Would you buy back in or something better such as ATA or BOYD or CAE.
It's classified as basic material on many websites but industrial on yours.

Q: Hi Peter and staff,

On Sep. 13 I asked about possible new purchases, and one of the recommendations was UPST. So I'm looking at the chart and it looks like it's on a free fall for the last year, although it has stabilized recently.
I went back and checked on past Q&A and your view was not positive for UPST. You recommended AFRM over UPST and you mentioned that the fundamentals and potential have deteriorated.
I also checked and it appears that right now there are 2 Buys, 6 Holds and 1 underperform.
Just wondering what new information you have that would make this a buy.

As always thank you for your advice.

Joe

Q: Can you comment on the spinoff news at BAM? Some details were disclosed and it sounds bullish but would appreciate your perspective.

Q: I'm looking at increasing my exposure to quality small cap companies. This company seems to be run by strong capital allocators, and I'm wondering if you can foresee strong compounding potential in its future?